Array
(
[direction] => 1
[market_status] => green
)SP Tulsian, sptulsian.com don‘t think that Dishman Pharma can correct below Rs 84-85. He feels the major correction seems to have got factored in. However, he still feels one should not invest in Dishman Pharma even at current levels.
first published: Feb 11, 2013 07:20 pm
A collection of the most-viewed Moneycontrol videos.

Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions

AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation

Live: Broader markets outperform this week; Metal, realty top sectoral plays | Closing Bell

Trump Signals Major Breakthrough In Iran Deal, May Visit Islamabad Soon
You are already a Moneycontrol Pro user.


